ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: PP05

Integrative Approach to Treatment of an Adult with Juvenile Rheumatoid Arthritis

Shannan O'Hara-Levi, Patient, Staten Island, NY

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Integrative, Juvenile Arthritis, patient and patient health

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: 3S041 ACR/ARHP: Patient Perspectives Poster Session

Session Type: Patient Perspectives Poster Session

Session Time: 12:00PM-2:00PM

Background/Diagnosis:

I was diagnosed in 1987 at age 3 with Polyarticular Juvenile Rheumatoid Arthritis which effected every joint in my body. At time of diagnosis I was expected to be in a wheelchair by age 6. With the help of NSAIDs, prednisone and Gold Injections, this was not the case. Eventually, I began trials of various drug cocktails that included those previously listed with the addition of DMARDs, namely Methotrexate and Plaquenil, and a rotation of various supplements including shark cartilage and vitamins. The ever changing trials of these cocktails continued until my mid-teenage years when biologic medication was introduced. After trying many different biologic medications and having varying results, I was taken off those medications and maintained on prednisone and Methotrexate for the time being. However, disease progression continues resulting in bilateral shoulder replacements in 2018.

Treatment:  

I have adapted an integrative approach to my treatment plan along with my medical team. This approach includes incorporating vitamin supplements and dietary restrictions under the supervision and recommendation of my rheumatologist and regular walking.

Maintenance:  

Prior to adding an integrative approach to my treatment, I was trying and most often failing drugs and drug cocktails regularly, which become stressful and disappointing. By adding specific supplements picked out by my doctor, I have guidance as to what is working for my body. In addition, dietary restrictions have improved my health and given me a sense of control over my illness. I use this sense of control to ensure that not only do I take my supplements and eat well; I move my body in one of the few ways it can regularly by walking daily. By ensuring that these integrative approaches are a regular part of my lifestyle, I am able to work better with my medical team as I am able to have some control of these treatments which will hopefully lead to decreased disease progression.

Quality of Life: 

Due to recent changes in my disease progression, the addition of these integrative approaches has ultimately led me to having a better quality of life. I am able to see these additions of supplements and dietary changes as a privilege instead of an additional burden of this disease because I do have some sort of control here. Walking has given me a boost of self-confidence as I “compete” with friends and family thru an app that tracks my walking. This added bonus is not only fun but keeps me accountable in a positive way. Prior to these changes, I was disappointed in my health and disease progression. Now, I am more confident in having a fun, healthy way of taking control over my health.

SOLbraces.PNGSOLwalk.PNG


Disclosure: S. O'Hara-Levi, None;

To cite this abstract in AMA style:

O'Hara-Levi S. Integrative Approach to Treatment of an Adult with Juvenile Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/integrative-approach-to-treatment-of-an-adult-with-juvenile-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/integrative-approach-to-treatment-of-an-adult-with-juvenile-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology